Skip Page Header

Home > EMCDDA-Europol joint report on a new psychoactive substance: 4-methylamphetamine.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) EMCDDA-Europol joint report on a new psychoactive substance: 4-methylamphetamine. Luxembourg: Publications Office of the European Union. 40 p.

[img] PDF (EMCDDA-Europol - 4-methylamphetamine) - Published Version
340kB

At the end of 2011 and in 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methylamphetamine. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 4-methylamphetamine as stipulated by Article 5.1 of the Decision.

Table of contents
• Introduction
• Information collection process
• Information required by Article 5.2 of the Decision
• Information from the EMA as requested by Article 5.3 of the Decision
• Summary of findings
• Conclusions
• Annexes


Item Type
Evidence resource
Publication Type
Report
Drug Type
New psychoactive substance, CNS stimulants
Intervention Type
AOD disorder harm reduction
Source
Date
2012
Pages
40 p.
Publisher
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
EndNote
Accession Number
HRB (Electronic Only)
Related URLs

Repository Staff Only: item control page